Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
Key Highlights
- ➤Ocugen (OCGN) will report third quarter 2026 financial results November 4
- ➤Business update scheduled alongside results at 8:30 a.m. ET
- ➤Ocugen advances modifier gene therapies for inherited retinal diseases and blindness
MALVERN, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, will host a conference call and live webcast on Wednesday, November 4, 2026, at 8:30 a.m. ET to provide a business update and report third quarter 2026 financial results. All related materials will be made available on the Ocugen investor website prior to the start of the call.
Conference Call Details Date: Wednesday, November 4, 2026 Time: 8:30 a.m. ET Webcast: https://edge.media-server.com/mmc/p/w8rytgud Participant Event Dial-ins: +1(800)715-9871 for US callers and +1(646)307-1963 for international callers Participant Access Code: 6835403
Get started
Create a free account to read the full story.